Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mae Thamer

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 2015
Predicting Early Death Among Elderly Dialysis Patients: Development and Validation of a Risk Score to Assist Shared Decision Making for Dialysis InitiationMae Thamer, James S Kaufman, Yi Zhang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 26, 2024
Hepatitis Delta Virus Testing and Prevalence Among Chronic Hepatitis B Patients Across Three U.S. Safety-net Health SystemsRobert J Wong, Mamta K Jain, Bolin Niu, et al.
Open Forum Infectious Diseases|October 16, 2024
Sociodemographic Disparities in Hepatitis B Treatment: A Real-World Analysis of 3 Safety-Net Health Systems in the United StatesRobert J Wong, Mamta K Jain, Bolin Niu, et al.
The American Journal of Gastroenterology|March 4, 2021
Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health SystemsRobert J Wong, Mamta K Jain, George Therapondos, et al.
Journal of Clinical Gastroenterology|March 29, 2021
Low Rates of Hepatitis B Virus Treatment Among Treatment-Eligible Patients in Safety-Net Health SystemsRobert J Wong, Mamta K Jain, George Therapondos, et al.
Journal of Viral Hepatitis|July 4, 2023
Persistent low prevalence of hepatitis B vaccination among people with HIV: Time for a change?Angie Garcia, Karen J Vigil, Barbara Taylor, et al.
Kidney360|April 25, 2025
Patient-Centered Intervention in Advance Care Planning Across Dialysis Organizations: HIGHWay: Honor Individual Goals and HopesGiselle M Rodriguez de Sosa, Mae Thamer, Elizabeth Anderson, et al.
Hepatology (Baltimore, Md.)|July 19, 2018
Has Access to Hepatitis C Virus Therapy Changed for Patients With Mental Health or Substance Use Disorders in the Direct-Acting-Antiviral Period?Mamta K Jain, Mae Thamer, George Therapondos, et al.
The American Journal of Gastroenterology|March 11, 2018
Race/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatmentRobert J Wong, Mamta K Jain, George Therapondos, et al.
Journal of Clinical and Experimental Hepatology|March 20, 2020
Sustained Improvements in Markers of Liver Disease Severity After Hepatitis C TreatmentRobert J Wong, Mamta K Jain, George Therapondos, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 2015
Predicting Early Death Among Elderly Dialysis Patients: Development and Validation of a Risk Score to Assist Shared Decision Making for Dialysis InitiationMae Thamer, James S Kaufman, Yi Zhang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 26, 2024
Hepatitis Delta Virus Testing and Prevalence Among Chronic Hepatitis B Patients Across Three U.S. Safety-net Health SystemsRobert J Wong, Mamta K Jain, Bolin Niu, et al.
Open Forum Infectious Diseases|October 16, 2024
Sociodemographic Disparities in Hepatitis B Treatment: A Real-World Analysis of 3 Safety-Net Health Systems in the United StatesRobert J Wong, Mamta K Jain, Bolin Niu, et al.
The American Journal of Gastroenterology|March 4, 2021
Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health SystemsRobert J Wong, Mamta K Jain, George Therapondos, et al.
Journal of Clinical Gastroenterology|March 29, 2021
Low Rates of Hepatitis B Virus Treatment Among Treatment-Eligible Patients in Safety-Net Health SystemsRobert J Wong, Mamta K Jain, George Therapondos, et al.
Journal of Viral Hepatitis|July 4, 2023
Persistent low prevalence of hepatitis B vaccination among people with HIV: Time for a change?Angie Garcia, Karen J Vigil, Barbara Taylor, et al.
Kidney360|April 25, 2025
Patient-Centered Intervention in Advance Care Planning Across Dialysis Organizations: HIGHWay: Honor Individual Goals and HopesGiselle M Rodriguez de Sosa, Mae Thamer, Elizabeth Anderson, et al.
Hepatology (Baltimore, Md.)|July 19, 2018
Has Access to Hepatitis C Virus Therapy Changed for Patients With Mental Health or Substance Use Disorders in the Direct-Acting-Antiviral Period?Mamta K Jain, Mae Thamer, George Therapondos, et al.
The American Journal of Gastroenterology|March 11, 2018
Race/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatmentRobert J Wong, Mamta K Jain, George Therapondos, et al.
Journal of Clinical and Experimental Hepatology|March 20, 2020
Sustained Improvements in Markers of Liver Disease Severity After Hepatitis C TreatmentRobert J Wong, Mamta K Jain, George Therapondos, et al.
Pageof 5